Skip to main navigation Skip to search Skip to main content

Response by Kosiborod et al to Letter Regarding Article, "effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients with Heart Failure with Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial"

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e226-e227
JournalCirculation
Volume150
Issue number10
DOIs
StatePublished - Sep 3 2024

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this